CCL3



CCL3

S1SS1L2LL2A3AA3A4AA4D5DD5T6TT6P7PP7T8TT8A9AA9C10CC10C11CC11F12FF12S13SS13Y14YY14T15TT15S16SS16R17RR17Q18QQ18I19II19P20PP20Q21QQ21N22NN22F23FF23I24II24A25AA25D26DD26Y27YY27F28FF28E29EE29T30TT30S31SS31S32SS32Q33QQ33C34CC34S35SS35K36KK36P37PP37G38GG38V39VV39I40II40F41FF41L42LL42T43TT43K44KK44R45RR45S46SS46R47RR47... and 22 more residue(s)...... and 22 more residue(s)

SMILES None
InChIKey None
Sequence SLAADTPTACCFSYTSRQIPQNFIADYFETSSQCSKPGVIFLTKRSRQVCADPSEEWVQKYVSDLELSA

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections

Structure pdb 7F1Q 7F1T

No bioactivity data available.

CCL3

S1SS1L2LL2A3AA3A4AA4D5DD5T6TT6P7PP7T8TT8A9AA9C10CC10C11CC11F12FF12S13SS13Y14YY14T15TT15S16SS16R17RR17Q18QQ18I19II19P20PP20Q21QQ21N22NN22F23FF23I24II24A25AA25D26DD26Y27YY27F28FF28E29EE29T30TT30S31SS31S32SS32Q33QQ33C34CC34S35SS35K36KK36P37PP37G38GG38V39VV39I40II40F41FF41L42LL42T43TT43K44KK44R45RR45S46SS46R47RR47... and 22 more residue(s)...... and 22 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections

Structure pdb 7F1Q 7F1T

Compound is not listed as a drug.